What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Gene
- Enzyme
Internal medicine, Endocrinology, Cholesterol, ABCA1 and Lipoprotein are his primary areas of study.
His Internal medicine study frequently intersects with other fields, such as Lecithin.
In the subject of general Endocrinology, his work in Apolipoprotein B, Adipose tissue and Hypertriglyceridemia is often linked to Context, thereby combining diverse domains of study.
His ABCA1 study is related to the wider topic of Biochemistry.
His research investigates the connection between Biochemistry and topics such as Cell biology that intersect with problems in Regulation of gene expression, Receptor and microRNA.
His work carried out in the field of Lipoprotein brings together such families of science as Pregnancy, Birth weight, Case-control study, Retrospective cohort study and Complication.
His most cited work include:
- MicroRNAs are transported in plasma and delivered to recipient cells by high-density lipoproteins (1876 citations)
- PPAR-alpha and PPAR-gamma activators induce cholesterol removal from human macrophage foam cells through stimulation of the ABCA1 pathway. (986 citations)
- Cholesterol Efflux and Atheroprotection Advancing the Concept of Reverse Cholesterol Transport (595 citations)
What are the main themes of his work throughout his whole career to date?
Alan T. Remaley mostly deals with Internal medicine, Endocrinology, Cholesterol, Lipoprotein and Biochemistry.
Alan T. Remaley combines subjects such as Gastroenterology and Cardiology with his study of Internal medicine.
His studies in Endocrinology integrate themes in fields like Inflammation and Apolipoprotein E.
His study looks at the relationship between Cholesterol and fields such as ABCA1, as well as how they intersect with chemical problems.
His work on Immunology expands to the thematically related Lipoprotein.
Particularly relevant to Peptide is his body of work in Biochemistry.
He most often published in these fields:
- Internal medicine (49.74%)
- Endocrinology (41.27%)
- Cholesterol (28.92%)
What were the highlights of his more recent work (between 2017-2021)?
- Internal medicine (49.74%)
- Lipoprotein (22.22%)
- Endocrinology (41.27%)
In recent papers he was focusing on the following fields of study:
His primary areas of investigation include Internal medicine, Lipoprotein, Endocrinology, Cholesterol and Apolipoprotein B.
His Internal medicine study integrates concerns from other disciplines, such as Gastroenterology, Psoriasis and Cardiology.
His Lipoprotein research is multidisciplinary, relying on both Inflammation, Dyslipidemia and Cell biology.
His is involved in several facets of Endocrinology study, as is seen by his studies on Lipoprotein lipase, Insulin resistance, Type 1 diabetes, Obesity and Lecithin—cholesterol acyltransferase.
Alan T. Remaley regularly ties together related areas like Biophysics in his Cholesterol studies.
His Apolipoprotein B study frequently links to related topics such as Peptide.
Between 2017 and 2021, his most popular works were:
- NHLBI Working Group Recommendations to Reduce Lipoprotein(a)-Mediated Risk of Cardiovascular Disease and Aortic Stenosis. (150 citations)
- Quantifying Atherogenic Lipoproteins : Current and Future Challenges in the Era of Personalized Medicine and Very Low Concentrations of LDL Cholesterol. A Consensus Statement from EAS and EFLM (88 citations)
- Quantifying atherogenic lipoproteins for lipid-lowering strategies: consensus-based recommendations from EAS and EFLM (46 citations)
In his most recent research, the most cited papers focused on:
- Internal medicine
- Gene
- Enzyme
Alan T. Remaley mainly focuses on Cholesterol, Internal medicine, Lipoprotein, Apolipoprotein B and Endocrinology.
His work deals with themes such as Proteome and Proteomics, which intersect with Cholesterol.
His Internal medicine research includes elements of Gastroenterology and Cardiology.
His Lipoprotein research includes themes of Biophysics, Cell biology and Insulin resistance.
Alan T. Remaley has included themes like Efflux, Lipoprotein lipase, Apolipoprotein C-II and Lipid microdomain in his Apolipoprotein B study.
Many of his studies on Endocrinology apply to Case-control study as well.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
